Changzhou Institute of Materia Medica Co., Ltd. is a national high-tech enterprise integrating R&D, manufacturing and application. It is the earliest scientific research institution specializing in the research of medical sodium hyaluronate in the country. The predecessor was the provincial state-owned scientific research founded in 1984. The unit, completed the restructuring in November 2010. The company has built a modern new factory with a total area of 30,000 square meters, of which the GMP standard purification workshop (cleaning level: Class 10,000 + 100) covers an area of 12,000 square meters, and the R&D center has an area of more than 3,000 square meters.
The company has more than 140 employees, 35 scientific researchers, and 10 have intermediate and senior titles. The company has been recognized as a national high-tech enterprise, a gazelle enterprise in the Southern Jiangsu National Independent Innovation Demonstration Zone, and a small and medium-sized science and technology enterprise in Jiangsu Province. At the same time, the company has established a Jiangsu Province Biomedical Material Engineering Technology Research Center, a Jiangsu Province Postdoctoral Research Station, and Jiangsu Province. Provincial Foreign Expert Studio and Jiangsu Provincial Enterprise Graduate Workstation; In June 2017, the company wholly established Changzhou Yunyu Biomaterials Research Institute.
The company attaches great importance to scientific and technological research and development, technical cooperation, intellectual property protection and other work. The company and the Institute of Natural and Medical Sciences (NMI) of the University of Tubingen in Germany jointly established a collagen product laboratory, and launched a joint development of spider silk protein products with the School of Materials of Tsinghua University, and signed agreements with Jiangnan University, Xi'an Jiaotong University, Changzhou University, etc. Cooperation agreement to jointly develop pharmaceutical products. The company currently has 43 authorized patents, including 16 invention patents and 10 utility model patents; 17 copyrights have been registered.
In addition, while continuously increasing investment in hardware facilities, the company has also established a complete quality management system, and has successively obtained ISO9001:2015 quality management system certification, ISO13485:2016 medical device quality management system certification, and GB/T29490-2013 intellectual property rights Quality management system certification, EU EN ISO13485 certification.
The main business direction of the company is medical equipment, medical materials and medical skin care products. Product categories include: surgery, ophthalmology, medical beauty, skin care products, etc. Three major product series have been formed, mainly including Yishukang®, Bicuishi® and Mishuizhiting®.
In the future, the company will further increase investment in scientific research, attract domestic and foreign scientific and technological talents, enrich the talent team, and improve the level of scientific research; strengthen cooperation and exchanges with colleges and universities to promote the upgrading of high-tech industrial technologies; further improve the quality management system and strengthen comprehensive Quality Control. Use technology, achievements and talents to help companies move towards a better future.
1025 Liaohe Road, Changzhou City, Jiangsu Province
Focus on us
Focus on us
Focus on us
Copyright©2023 All Rights Reserved of Changzhou Pharmaceutical Research Institute Co., Ltd.